CRSP:NASDAQ
크리스퍼 테라퓨틱스
US$49.88
arrow_upward
+1.28%(+0.63) 1D
10월 19일, 오후 2시 1분 24초 GMT-4 · USD
search
모든 종목 코드
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoCRSP의 주요 통계 생성 중...
시가
US$49.83
고가
US$50.29
저가
US$49.09
시가총액
48.14억
평균 거래량
166.12만
거래량
50.15만
52주 최고가
US$75.06
52주 최저가
US$44.12
EPS
-US$4.76
베타
1.45
유통 주식수
9669.30만
직원 수
393
시가
US$49.83
고가
US$50.29
저가
US$49.09
시가총액
48.14억
평균 거래량
166.12만
거래량
50.15만
52주 최고가
US$75.06
52주 최저가
US$44.12
EPS
-US$4.76
베타
1.45
유통 주식수
9669.30만
직원 수
393
뉴스 기사
웹 소스 및 뉴스 파트너 제공
The Motley Fool
·
19시간 전
Where Will CRISPR Therapeutics Stock Be in 2030?
프로필
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts, won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
크리스퍼 테라퓨틱스에 관한 정보